Loading
Modus Therapeutics Holding AB (publ) Stock: price and insider trades · Sweden
Modus Therapeutics Holding AB (publ): what insiders have been doing
We have very little insider data for Modus Therapeutics Holding AB (publ) so far: the most recent filing dates from 24 April 2026. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 0.39
Analyst consensus
Income statement
EBITDA-SEK 18.1M
Net income-SEK 18.5M0.0% margin
Valuation
P/Book8.0x
Beta0.38
Balance sheet & cash
Market capSEK 57.3M
Free Cash Flow-SEK 18.1M
Profitability & ownership
ROE-743.9%
ROA-167.5%
% insiders71.1%
% institutions8.7%
Last declaration on 24 April 2026
Declarations1 total
14,674,599 shares0TeckningsoptionISIN SE0025667512FI:A003X792-1
1 of 1 declaration
About Modus Therapeutics Holding AB (publ)
Modus Therapeutics Holding AB (publ) is a biopharmaceutical company focused on developing treatments for chronic diseases. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
